Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 28, 2020; 26(32): 4817-4832
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4817
Table 4 The comparison of human leukocyte antigen alleles which increase or decrease the duodenal ulcer risk in duodenal ulcer subgroup in terms of CagA+(≥ 2) EPIYA-C, n (%)
DU (≥ 2) EPIYA-C (n = 14, alleles = 28)DU (< 2) EPIYA-C (n = 36, alleles = 72)ORc95%CIP value
MinimumMaximum
HLA-A*0210 (36)20 (27)1.440.533.620.4380
HLA-B*354 (14)14 (19)0.800.240.6800.0201
HLA-DRB1*136 (21)6 (8)30.8710.260.0801
HLA-DQA1*0110 (36)26 (36)0.90.392.440.9704
HLA-DQB1*068 (28)16 (22)1.40.523.750.5340